OsteoPrime Ultra
Natural health product licensed in Canada
- Other names
- OsteoPrime Plus
- Licence holder
- Nature's Way of Canada Ltd.
- NPN or DIN-HM
- 80057175
- Status
- Active licence
- Licence date
- 12 January 2015
- Revision date
- 22 October 2018
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 6.25 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Chrome: up to 50 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamin K2 Source : Ménaquinone 7 | 11.25 mcg | 11.25 µg |
| Vitamine C | 30 mg | 30,000 µg |
| Acide d-pantothénique | 5 mg | Not calculated |
| Vitamine B6 | 6.25 mg | 6,250 µg |
| Vitamine B12 | 12.5 mcg | 12.5 µg |
| Vitamine D | 5 mcg | 5 µg |
| Vitamine D | 200 UI | 5 µg |
| 3-Pyridinecarboxamide | 12.5 mg | Not calculated |
| Folate | 200 mcg | Not calculated |
| Calcium | 200 mg | 200,000 µg |
| Phosphore | 32 mg | 32,000 µg |
| Magnésium | 75 mg | 75,000 µg |
| Zinc | 5 mg | 5,000 µg |
| Sélénium | 25 mcg | 25 µg |
| Cuivre | 500 mcg | 500 µg |
| Manganèse | 1.75 mg | 1,750 µg |
| Chrome | 50 mcg | 50 µg |
| Molybdène | 12.5 mcg | 12.5 µg |
| Sel interne d'hydroxyde de (carboxyméthyl)triméthylammonium | 5 mg | Not calculated |
| Strontium | 1,500 mcg | Not calculated |
| Silicium | 1,250 mcg | Not calculated |
| Bore | 750 mcg | Not calculated |
Non-medicinal ingredients
Acide stéarique, Caséinate de sodium, Cellulose, Glycérine, Croscarmellose de sodium, Dioxyde de silicium, Stéarate de magnésium, Cire de Carnauba
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Helps in the development and maintenance of bones. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis / may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life). Helps maintain healthy calcium metabolism. Helps in the development and maintenance of bones and teeth. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in the absorption and use of calcium and phosphorus. A factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If symptoms worsen, consult a health care practitioner. Consult a health care practitioner prior to use if you have been diagnosed with estrogen-dependant cancer. Consult a health care practitioner prior to use if you are taking antiplatelet medication or blood thinners. Consult a health care practitioner prior to use if you have gallstones or a bile duct obstruction. Consult a health care practitioner prior to use if you have a liver disorder. Consult a health care practitioner prior to use if you have cardiovascular disease. Consult a health care practitioner prior to use if you have a kidney disorder.
Source
Official Health Canada record, licence 80057175
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging